Greenstein Leonard M. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-08+40,097→ 40,097 totalExercise: $15.00Exp: 2033-03-08→ Common Stock (40,097 underlying) - Award
Restricted Stock Units
2023-03-08+27,160→ 27,160 total→ Common Stock (27,160 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.